Docarpamine
|
|
Docarpamine Eigenschaften
- Schmelzpunkt:
- 85-90°; mp 105-108° (Nishiyama, 1992)
- alpha
- D20 -15.6° (c = 2 in methanol)
- Siedepunkt:
- 731.0±60.0 °C(Predicted)
- Dichte
- 1.222±0.06 g/cm3(Predicted)
- pka
- 14.51±0.46(Predicted)
Sicherheit
Toxizit?t | LD50 in male, female rats (mg/kg): 1000-1400, ~1000 s.c.; in rats, dogs (mg/kg): _>2000 orally (Nishiyama, 1992) |
---|
Docarpamine Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Docarpamine is a cardiostimulant with diuretic activity launched in Japan for the treatment of circulatory insufficiency. It is an orally effective peripheral dopamine prodrug that is well absorbed from the gastrointestinal tract and converted to dopamine in vivo, which exerts renal vasodilatory and natriuretic effects by activating renal dopamine (DA1) receptors, and a positive inotropic effect by activating cardiac β1-receptors. It has been reported to be effective in treating patients with acute heart failure, shock and acute renal failure.Verwenden
Docarpamine maybe a usefule alternative to intravenous dopamine after cardiac surgery.Docarpamine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Docarpamine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 11)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19553 | 58 |
RR Scientific LLC | +86-13917743231 |
sales@rrscientific.com | United States | 878 | 58 |
SHANGHAI HOHANCE CHEMICAL CO.,LTD | 021-31115312 18217084087 |
mary@hohance.com | China | 145 | 62 |
Hubei Shishun Biotechnology Co. Ltd | 027-59223025 15107168801 |
1718480011@qq.com | China | 9847 | 58 |
Hubei Guangao Biotechnology Co., Ltd | 027-027-59223056 18162699093 |
1208480011@qq.com | China | 9924 | 58 |
Hubei Qifei Pharmaceutical Chemical Co., Ltd | 027-027-59322506 18071128681 |
1438082200@qq.com | China | 9975 | 58 |
R.R Scientific, LLC. | 15010167677 |
zhiyuu1218@163.com | China | 876 | 58 |
Shaanxi Didu New Material Co., Ltd | 029-029-63373950 15353716720 |
1052@dideu.com | China | 10002 | 58 |
Weifu (Shanghai) Pharmaceutical Technology Co., LTD | 021-31115312 13917553503 |
401919639@qq.com | China | 237 | 58 |
TLC Pharmaceutical Standards Ltd. | 18012923235; 18012923235 |
chinasales04@tlcstandards.com.cn | China | 4928 | 58 |
- Docarpamine
- Carbonic acid, 4-[2-[[(2S)-2-(acetylamino)-4-(methylthio)-1-oxobutyl]amino]ethyl]-1,2-phenylene diethyl ester
- Carbonic acid, 4-[2-[[2-(acetylamino)-4-(methylthio)-1-oxobutyl]amino]ethyl]-1,2-phenylene diethyl ester, (S)-
- TA 870
- Tanadopa
- (S)-2-(Acetylamino)-N-[3,4-bis(ethoxycarbonyloxy)phenethyl]-4-(methylthio)butanamide
- 3,4-Bis[(ethoxycarbonyl)oxy]-N-(N-acetyl-L-methionyl)benzeneethanamine
- TA-8704
- Carbonic acid, C,C'-[4-[2-[[2-(acetylamino)-4-(methylthio)-1-oxobutyl]amino]ethyl]-1,2-phenylene] C,C'-diethyl ester
- 4-{2-[(N-Acetyl-L-methionyl)amino]ethyl}-1,2-phenylenediethylbiscarbonate
- 74639-40-0
- C21H30N2O8S